News

VF Board President Talks About Personal Impact of Vasculitis on Rare Disease Day 2017

VF Board President, Karen Hirsch, appeared on Good Morning Washington, WJLA in Washington D.C. to discuss the importance of raising awareness about all rare diseases on Rare Disease Day 2017.   more »


Read More

Introducing Dr. Jennifer Rodrigues – 2016-17 VCRC-VF Fellow

The Vasculitis Foundation welcomes Dr. Jennifer Rodrigues, as our 2016-2017 VCRC-VF Fellow.  Dr. Rodrigues completed medical school at the University of Calgary in 2011, her Internal Medicine training at McGill more »


Read More

VF Partners with Northwestern University to Open Vasculitis Program

The Vasculitis Foundation and Northwestern Memorial Hospital’s Division of Rheumatology have launched the health system’s first Vasculitis Clinical Research Program. Vasculitis is an immune system disorder that causes destructive inflammation more »


Read More

Support the 2016 VF Annual Appeal

When you or a family member was diagnosed with vasculitis, where did you turn?  If you’re like many in our community, you turned to the Vasculitis Foundation. Over the past more »


Read More

Breakthrough Therapy for Patients with Giant Cell Arteritis

FDA Grants Breakthrough Therapy Designation for GENENTECH’S Actemra® (tocilizumab) in Giant Cell Arteritis, A form of vasculitis Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced more »


Read More

Support the VF through the Amazon Smile Program

Just in time for your holiday shopping! AmazonSmile is a simple and automatic way for you to support the Vasculitis Foundation every time you shop, at no cost to you. more »


Read More

Brandon Qualifies for the 1500m Semi-Finals – Competes July 8th

Brandon Hudgins, elite runner, and vasculitis patient, continues his quest to make the 2016 U.S. Olympic Team!  On Thursday, July 7th, Brandon qualified for the semi-finals of the 1500m race more »


Read More

KU Vasculitis Symposium – August 6 – Register Today

The Vasculitis Foundation is pleased to partner with the University of Kansas Medical Center to present the 2016 Vasculitis Symposium Educational Conference.  The one-day meeting will be held on Saturday, more »


Read More

VF Breaks $2,000,000 in Research Funding

In February, the VF Board of Directors approved three new research studies for funding, bringing to a total, $2,109,847,10, the VF has committed to supporting vasculitis research since 2002.  The more »


Read More

EU Project Aims to Improve Diagnostics and Intervention Strategies

A new project funded by the European Commission (Horizon 2020) is devoted to the research of chronic autoimmune diseases such as rheumatoid arthritis and vasculitis and the development of individualised more »


Read More
« Previous PageNext Page »Next Page »« Previous Page